ImmunityBio Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.37 (market cap $10.51B), while XPO Inc. Common Stock trades at $181.35 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 2× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and XPO Inc. Common Stock for 0 Days on average.
| IBRX | XPO | |
|---|---|---|
Market Cap | $10.51B | $21.30B |
Volume | 10,445,785 | 897,705 |
Sector | Health | Industrials |
52-Week High | $11.55 | $228.37 |
52-Week Low | $1.98 | $123.66 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $24.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →